Factors affecting drug concentrations and QT interval during thioridazine therapy. [electronic resource]
Producer: 20071128Description: 555-65 p. digitalISSN:- 1532-6535
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Alleles
- Antipsychotic Agents -- administration & dosage
- Aryl Hydrocarbon Hydroxylases -- genetics
- Cross-Sectional Studies
- Cytochrome P-450 CYP2C19
- Cytochrome P-450 CYP2D6 -- genetics
- Dopamine Antagonists -- adverse effects
- Female
- Genetic Variation
- Genotype
- Heart Conduction System -- drug effects
- Humans
- Linear Models
- Long QT Syndrome -- blood
- Male
- Mesoridazine -- adverse effects
- Middle Aged
- Mixed Function Oxygenases -- genetics
- Risk Factors
- Schizophrenia -- drug therapy
- Sex Factors
- Smoking -- adverse effects
- Thioridazine -- administration & dosage
- White People -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.